Effect of Berebris vulgaris on Metabolic Syndrome Components

Phase 2

• Conditions: Type 2 Diabete.; Diabetes Mellitus; E10, E11,

• Registration Number: IRCT201107096984N1
• Lead Sponsor: utritional Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 65

Inclusion Criteria

obesity (BMI>30kg/m2) or WHR>0.9(men) and 0.8(women); hypertriglyceridemia (TG>150 mg/dl); HDL<35(men) and <39(women); hypertension >90/140mmHg.
Exclusion criteria: renal, hepatic, gastrointestinal and thyroid disease; diet therapy; insulin therapy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glucose. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Biochemistery analysis.;Blood pressure. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Manometer.;Malondialdehyde. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Biochemistery analysis.;Inflammatoru indices. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Biochemistery analysis.;Insulin. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Biochemistery analysis.;Anthropometric Indices. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Bioelectric impedance.;Lipid profile. Timepoint: Baseline and 2, 4 and 8 weeka after intervention. Method of measurement: Biochemistery analysis.